Traders sold shares of Boston Scientific Corp. (NYSE:BSX) on strength during trading on Thursday. $19.61 million flowed into the stock on the tick-up and $41.46 million flowed out of the stock on the tick-down, for a money net flow of $21.85 million out of the stock. Of all companies tracked, Boston Scientific Corp. had the 0th highest net out-flow for the day. Boston Scientific Corp. traded up $0.15 for the day and closed at $23.78

A number of equities research analysts have weighed in on the company. TheStreet raised Boston Scientific Corp. from a “hold” rating to a “buy” rating in a research report on Wednesday, April 27th. BTIG Research lowered Boston Scientific Corp. from a “buy” rating to a “neutral” rating and set a $24.20 price target for the company. in a research report on Monday, May 23rd. Benchmark Co. reissued a “buy” rating and issued a $22.00 price target (up from $20.00) on shares of Boston Scientific Corp. in a research report on Wednesday, April 27th. Bank of America Corp. reissued a “buy” rating and issued a $23.00 price target on shares of Boston Scientific Corp. in a research report on Friday, March 25th. Finally, Zacks Investment Research raised Boston Scientific Corp. from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Thursday, May 12th. Four investment analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $23.49.

The firm’s market capitalization is $31.99 billion. The firm has a 50-day moving average price of $23.01 and a 200-day moving average price of $19.89.

Boston Scientific Corp. (NYSE:BSX) last posted its earnings results on Wednesday, April 27th. The company reported $0.28 EPS for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.04. The firm had revenue of $1.96 billion for the quarter, compared to analyst estimates of $1.91 billion. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. Equities analysts forecast that Boston Scientific Corp. will post $1.09 earnings per share for the current fiscal year.

In other news, CEO Michael F. Mahoney sold 100,000 shares of Boston Scientific Corp. stock in a transaction dated Wednesday, June 1st. The stock was sold at an average price of $22.69, for a total transaction of $2,269,000.00. Following the sale, the chief executive officer now owns 1,532,577 shares in the company, valued at $34,774,172.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Timothy A. Pratt sold 24,229 shares of Boston Scientific Corp. stock in a transaction dated Wednesday, June 1st. The stock was sold at an average price of $22.66, for a total value of $549,029.14. Following the sale, the executive vice president now owns 301,724 shares in the company, valued at approximately $6,837,065.84. The disclosure for this sale can be found here.

Several hedge funds have recently bought and sold shares of BSX. PNC Financial Services Group Inc. boosted its stake in Boston Scientific Corp. by 7.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 57,502 shares of the company’s stock worth $1,061,000 after buying an additional 3,945 shares during the period. Suntrust Banks Inc. bought a new position in Boston Scientific Corp. during the fourth quarter worth about $1,438,000. Tredje AP fonden raised its position in Boston Scientific Corp. by 1.3% in the fourth quarter. Tredje AP fonden now owns 86,021 shares of the company’s stock worth $1,586,000 after buying an additional 1,138 shares in the last quarter. Commerzbank Aktiengesellschaft FI raised its position in Boston Scientific Corp. by 101.6% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 87,815 shares of the company’s stock worth $1,619,000 after buying an additional 44,248 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in Boston Scientific Corp. by 1.8% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 87,889 shares of the company’s stock worth $1,621,000 after buying an additional 1,540 shares in the last quarter.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.